[go: up one dir, main page]

AU2775692A - Recombinant influenza virus vaccine compositions - Google Patents

Recombinant influenza virus vaccine compositions

Info

Publication number
AU2775692A
AU2775692A AU27756/92A AU2775692A AU2775692A AU 2775692 A AU2775692 A AU 2775692A AU 27756/92 A AU27756/92 A AU 27756/92A AU 2775692 A AU2775692 A AU 2775692A AU 2775692 A AU2775692 A AU 2775692A
Authority
AU
Australia
Prior art keywords
influenza virus
vaccine compositions
virus vaccine
recombinant influenza
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27756/92A
Inventor
Susan B. Dillon
Christopher S. Jones
Miller O Scott
Allan Shatzman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU2775692A publication Critical patent/AU2775692A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/46—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU27756/92A 1991-08-30 1992-09-17 Recombinant influenza virus vaccine compositions Abandoned AU2775692A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75189891A 1991-08-30 1991-08-30
PCT/US1992/007312 WO1994006468A1 (en) 1991-08-30 1992-09-17 Recombinant influenza virus vaccine compositions

Publications (1)

Publication Number Publication Date
AU2775692A true AU2775692A (en) 1994-04-12

Family

ID=25023987

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27756/92A Abandoned AU2775692A (en) 1991-08-30 1992-09-17 Recombinant influenza virus vaccine compositions

Country Status (2)

Country Link
AU (1) AU2775692A (en)
WO (1) WO1994006468A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306404B1 (en) 1998-07-14 2001-10-23 American Cyanamid Company Adjuvant and vaccine compositions containing monophosphoryl lipid A
US6635261B2 (en) 1999-07-13 2003-10-21 Wyeth Holdings Corporation Adjuvant and vaccine compositions containing monophosphoryl lipid A
GB0022969D0 (en) * 2000-09-19 2000-11-01 Chiron Spa Influenza a virus subtype H16
AU2007297801A1 (en) 2006-07-14 2008-03-27 Sanofi Pasteur Biologics Co. Construction of recombinant virus vaccines by direct transposon-mediated insertion of foreign immunologic determinants into vector virus proteins
EP2069483A4 (en) 2006-09-29 2010-10-27 Sanofi Pasteur Biologics Co Recombinant rhinovirus vectors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01242254A (en) * 1988-03-24 1989-09-27 Canon Inc Apparatus and method for forming image

Also Published As

Publication number Publication date
WO1994006468A1 (en) 1994-03-31

Similar Documents

Publication Publication Date Title
AU2371692A (en) Recombinant hepatitis a virus vaccine
AP9400621A0 (en) Influenza vaccine compositions
EP0717636A4 (en) Malaria recombinant poxvirus vaccine
AP9300502A0 (en) Vaccine compositions
IL108915A0 (en) Polynucleotide vaccine against influenza virus
GB2246784B (en) Herpes virus recombinant poxvirus vaccine
AP9400629A0 (en) Vaccine compositions
AU6093296A (en) Infectious dengue 2 virus pdk-53 as quadravalent vaccine
AU1308495A (en) Influenza vaccine
AU4450093A (en) Hepatitis A virus vaccine
GB2264949B (en) Measles virus recombinant poxvirus vaccine
AU8684991A (en) Novel muramyldipeptide derivatives and influenza vaccine comprising the derivatives
AU1257092A (en) Interferon sensitive recombinant poxvirus vaccine
AU7617791A (en) Recombinant immunocastration vaccine
GB9326425D0 (en) Vaccine compositions
AU5679394A (en) Hepatitis b virus vaccines
IL101639A0 (en) Recombinant influenza vaccines
AU2775692A (en) Recombinant influenza virus vaccine compositions
AU6715094A (en) Recombinant vaccine
AU1668097A (en) Malaria recombinant poxvirus vaccine
AU6777490A (en) Malaria vaccine
AU2961195A (en) Chicken infectious anemia virus vaccine
AU2347692A (en) Recombinant viral vaccine
AU5358894A (en) Recombinant alliinase, its preparation and pharmaceutical compositions comprising it
AU1229492A (en) Live vaccine against colibacillosis